Thermo Fisher Buying Fermentas for $260 Million
Thermo Fisher Scientific Inc. (NYSE: TMO) has agreed to acquire Fermentas International Inc., a Burlington, Ontario-based maker of molecular biology products for use by researchers in university and commercial laboratories. The deal is valued at $260 million in cash. Summit Partners made a "significant minority investment" into Fermantas in 2007, but no financial terms were disclosed.
28 May 2010•3 mins read
